Sign In   Register

Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com

AgraFlora Organics International eyeing cultivation licence for large British Columbia greenhouse before end of second quarter

1 minute reading time (298 words)

Propagation Services Canada, otherwise known as the 'Delta Facility', is a 2.2 million square foot commercial greenhouse

On April 3 this year, AgraFlora said the Delta Facility had submitted responses to the third request for more information (RMI) from Health Canada over the cultivation application

AgraFlora Organics International Inc () (OTCMKTS:AGFAF) revealed it has taken a further step towards gaining a cultivation licence for its large-scale commercial greenhouse in Delta, British Columbia.

In a statement, the international cannabis firm confirmed that it will deliver the cultivation license at its Delta Facility before the end of the second quarter this year, barring any material change in Health Canada’s service standards as a result of "prevailing socioeconomic conditions".

READ: AgraFlora Organics nabs Health Canada approval to launch Toronto CBD business

The group's Propagation Services Canada, otherwise known as the 'Delta Facility', is a 2.2 million square foot commercial greenhouse, aiming to reshape the Canadian market with high-potency, low-cost cannabis flower.

On April 3 this year, AgraFlora said the Delta Facility had submitted responses to the third request for more information (RMI) from Health Canada over the cultivation application.

This was submitted to clarify information previously submitted to Health Canada on February 28 this year.

Last major step

"AgraFlora believes that the company has taken the last major step towards licensing, having submitted robust responses to Health Canada’s requests in February and now again in March," the firm told investors in a statement.

"Preparations have commenced to start cultivating once the license is obtained, including completing our genetics transaction to pursue our high-potency, low-cost product strategy."

Also in the statement, the group praised Health Canada and its individual employees for maintaining licensing operations as all parties navigate the challenges created by the coronavirus (COVID-19) crisis.

Contact the author at [email protected]


Related Posts


MjInvest.com